Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12–17 years in Singapore: a national cohort study

Singapore offered the BNT162b2 vaccine (tozinameran; Pfizer-BioNTech) to adolescents aged 12–17 years in May 18, 2021, and extended booster vaccines to this group in Jan 21, 2022. Literature on the effectiveness of primary series and booster vaccination among adolescents is scarce outside of Europe...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet infectious diseases 2023-02, Vol.23 (2), p.177-182
Hauptverfasser:	Chiew, Calvin J, Premikha, M, Chong, Chia Yin, Wei, Wycliffe E, Ong, Benjamin, Lye, David Chien, Heng, Derrick, Lee, Vernon J, Tan, Kelvin Bryan
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adolescents Age groups BNT162 Vaccine Cohort analysis Cohort Studies Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 vaccines Drug dosages Effectiveness Ethnicity Hospitalization Humans Infections Infectious diseases Intensive care Morbidity Observational studies Public health SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Singapore - epidemiology Socioeconomic factors Teenagers Vaccination Vaccine efficacy Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!